Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Early research (Phase 1)Study completedNCT04421352
What this trial is testing

Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients

Who this might be right for
Relapsed Small Cell Lung Cancer
CStone Pharmaceuticals 11
Not applicableStudy completedNCT00004138
What this trial is testing

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 303
Testing effectiveness (Phase 2)Study completedNCT04838548
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Lepu Biopharma Co., Ltd. 87
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Not applicableUnknownNCT06613308
What this trial is testing

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Capital Medical University 20
Testing effectiveness (Phase 2)Study completedNCT00034164
What this trial is testing

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Achieve Life Sciences 52
Testing effectiveness (Phase 2)Study completedNCT05077709
What this trial is testing

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Who this might be right for
Lung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder
IO Biotech 63
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Not applicableStudy completedNCT04775095
What this trial is testing

BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation

Who this might be right for
Non Small Cell Lung CancerBRAF V600 Mutation
Intergroupe Francophone de Cancerologie Thoracique 163
Not applicableLooking for participantsNCT07216209
What this trial is testing

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell
University of Arizona 48
Not applicableUnknownNCT00006087
What this trial is testing

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer

Who this might be right for
Lung Cancer
Jewish Hospital and St. Mary's Healthcare
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Early research (Phase 1)Study completedNCT02015416
What this trial is testing

Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer

Who this might be right for
MelanomaOvarian CancerSarcoma+2 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 13
Early research (Phase 1)Looking for participantsNCT05983432
What this trial is testing

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Who this might be right for
Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more
SystImmune Inc. 540
Not applicableStudy completedNCT01924416
What this trial is testing

Lung Cancer Information Study (LCIS-R01)

Who this might be right for
Non-Small-Cell Lung Cancer
University of Virginia 196
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Not applicableLooking for participantsNCT07176000
What this trial is testing

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Who this might be right for
Lung Carcinoma
Fred Hutchinson Cancer Center 237
Testing effectiveness (Phase 2)Looking for participantsNCT05956587
What this trial is testing

SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 121
Testing effectiveness (Phase 2)Ended earlyNCT00661011
What this trial is testing

Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy

Who this might be right for
Non Small Cell Lung Carcinoma
European Lung Cancer Working Party 75
Next Page